Continuous renal replacement therapies (CRRTs) are associated with a broad
pattern of additional metabolic effects beyond renal detoxification. Becaus
e of the continuous mode of therapy and the high fluid turnover usually ass
ociated with CRRTs, these side effects can become clinically relevant. With
many CRRT systems currently used, heat loss is considerable, but CRRTs can
also be used to modulate body temperature in hyperpyrectic patients. Inapp
ropriate glucose concentrations of some substitution fluids can result in e
xcessive glucose intake. Most substitution and/or dialysate fluids used for
CRRTs contain lactate as organic anion. In disease states with impaired la
ctate utilization, such as acute or chronic liver failure, and/or with incr
eased endogenous lactate formation such as in shock states, this can result
in hyperlactemia and is potentially associated with various adverse side e
ffects. Small molecular weight substances such as amino acids or water-solu
ble vitamins are lost in relevant amounts. With convective clearance and th
e high molecular cut-off of synthetic membranes, medium-sized molecules suc
h as hormones and cytokines are also filtered, but the pathophysiologic rel
evance of this observation remains to be specified. Moreover, synthetic mem
branes used for CRRTs have adsorptive properties for a variety of molecules
, such as cytokines, complement factors, and endotoxin. Continuous blood me
mbrane interactions cause the phenomena of bioincompatibility and a low-gra
de inflammatory reaction with potentially adverse consequences on protein m
etabolism and immunocompetence. In designing a nutritional program for a pa
tient on CRRT, these metabolic effects-especially the loss of nutritional s
ubstrates-must be considered. Certainly, most of these side effects, such a
s the excessive load of lactate or the loss of nutrients, are undesirable.
However, some side effects, such as the modulation of body temperature and
the elimination of endotoxin and/or mediators, might be at least potentiall
y beneficial.